Welcome to our dedicated page for Adapthealth SEC filings (Ticker: AHCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AdaptHealth Corp. filings document the company’s healthcare-at-home operations, financial reporting and public-company governance. Its Form 8-K disclosures include quarterly and annual earnings releases, Regulation FD updates, financial guidance, business highlights and material events related to operating partnerships, asset dispositions and executive leadership changes.
The filing record also covers capital structure and financing matters, including credit agreements entered into by AdaptHealth LLC and related guarantees, collateral and borrowing commitments. AdaptHealth’s proxy materials describe board and executive compensation matters, while its securities disclosures identify common stock trading under AHCO on the Nasdaq Stock Market.
AdaptHealth Corp ownership filing shows Dimensional Fund Advisors reports beneficial ownership of 6,920,973 shares of Common Stock, representing 5.1% of the class as of 03/31/2026. The filing states Dimensional has sole voting power over 6,793,155 shares and sole dispositive power over 6,920,973 shares, and includes a disclosure that the reported shares are owned by managed funds for which Dimensional acts as adviser and that Dimensional disclaims beneficial ownership.
AdaptHealth Corp. insiders reported open-market purchases of common stock by entities affiliated with One Equity Partners. OEP AHCO Investment Holdings, LLC bought 447,100 shares on March 20, 2026 at a weighted average price of $9.9121 per share and 727 shares on March 19, 2026 at a weighted average price of $9.9417 per share.
After these trades, the filing shows 16,312,698 shares of AdaptHealth common stock held indirectly following the latest transaction. The securities are held directly by OEP AHCO Investment Holdings, LLC, which is owned by several parallel One Equity Partners funds. A six-member investment committee of OEP VII GP, including Richard Cashin, may be deemed to have voting and investment discretion, though each reporting person disclaims beneficial ownership beyond its or his pecuniary interest.
AdaptHealth Corp. large shareholder entities affiliated with One Equity Partners reported open-market purchases of a total of 2,046,691 shares of common stock over three days in March. The shares were bought indirectly through OEP AHCO Investment Holdings, LLC at weighted average prices around $9.73 per share.
Purchases included 820,528 shares on March 10 at a weighted average price of $9.7287, 536,827 shares on March 11 at $9.7281, and 689,336 shares on March 12 at $9.7299. After these transactions, the affiliated entities reported indirect holdings of 15,864,871 AdaptHealth shares, with footnotes noting weighted-average pricing ranges and customary beneficial ownership disclaimers.
AdaptHealth Corp Schedule 13G/A amendment: The Vanguard Group reports no beneficial ownership of AdaptHealth Corp common stock, listing 0 shares and 0% of the class. The filing explains an internal realignment effective January 12, 2026 that led certain Vanguard subsidiaries and business divisions to report separately.
The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026. The disclosure states Vanguard entities retain the right to receive dividends or proceeds for managed accounts but that no single third party holds more than 5% of the class under the reported arrangement.
AdaptHealth Corp. saw a significant insider-related purchase as an entity associated with major holder Richard M. Cashin Jr. bought a total of 447,827 shares of common stock in open-market transactions on March 19 and 20, 2026. The shares were acquired indirectly through OEP AHCO Investment Holdings, LLC and related One Equity Partners funds, rather than by Cashin personally. After these purchases, the reporting group held 16,312,698 shares indirectly. The prices were reported as weighted averages, with trades executed in ranges between $9.81 and $9.95 per share.
AdaptHealth Corp. Chief Technology Officer Albert A. Prast exercised employee stock options to acquire 89,451 shares of common stock at $4.38 per share. To cover associated obligations, 58,203 shares of common stock were surrendered at $10.33 per share as a tax-withholding disposition. After these compensation-related transactions, Prast directly owns 474,155 shares of AdaptHealth common stock, reflecting a routine option exercise with part of the shares withheld rather than sold in the open market.
AdaptHealth Corp. reported that entities associated with major shareholder Richard M. Cashin Jr. made open-market purchases of 2,046,691 shares of common stock over three days. The shares were bought indirectly through OEP AHCO Investment Holdings, VI LLC at prices between $9.55 and $9.95 per share.
Following these transactions, the reporting group holds 15,864,871 shares of AdaptHealth common stock indirectly. Footnotes state that One Equity Partners funds own the investment vehicle, that an OEP VII GP investment committee including Cashin may be deemed to have voting and investment discretion, and that each reporting person disclaims beneficial ownership beyond their pecuniary interest.
AdaptHealth Corp. received an updated ownership filing from One Equity Partners–affiliated entities and Richard Cashin. This Amendment No. 4 to a Schedule 13D reports that the group of “Reporting Persons” may be deemed to beneficially own 15,864,871 shares of AdaptHealth common stock.
The filing states this position represents approximately 11.7% of the company’s common stock, based on 135,914,816 shares outstanding as of February 20, 2026, as reported in AdaptHealth’s Form 10-K. The shares are directly held by OEP AHCO Investment Holdings, LLC, which is owned by several Parallel Funds managed through OEP VII General Partner, L.P. and OEP VII GP, L.L.C.
The six-member investment committee of OEP VII GP, whose majority must include Richard Cashin, exercises voting and investment discretion over the reported securities, though the filing clarifies that no Reporting Person admits beneficial ownership for any other legal purpose. The group also notes that, within the prior 60 days, they acquired AdaptHealth shares in market transactions listed in an attached exhibit.
AdaptHealth Corp. director Susan T. Weaver reported a bona fide gift of 73,472 shares of AdaptHealth common stock, transferred to the Susan T. Weaver 2025 Irrevocable Trust for the benefit of her spouse and children. The filing lists the transaction as a gift transfer with no sale price.
After these transactions, Weaver directly holds 21,346 shares of AdaptHealth common stock and indirectly holds 73,472 shares through the irrevocable trust, reflecting a shift of ownership to a family estate-planning vehicle rather than a market sale.
AdaptHealth Corp. director Dale B. Wolf reported an open-market purchase of common stock. On February 27, 2026, he bought 8,000 shares of AdaptHealth common stock at a weighted average price of $8.96 per share.
After this transaction, Wolf directly owned 104,235 common shares. The filing also reports an additional 14,000 common shares held indirectly by a trust, reflecting indirect ownership separate from his direct holdings.